Combination anorexiant drug therapy for obesity using phentermin

Details Combination anorexiant drug therapy for obesity using phentermin Combination anorexiant drug therapy for obesity using phentermin

1997-06-13

1998-08-18

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514640, 514647, 514651, 514654, 514909, A61K 3150, A61K 31135, A61K 31495

Patent

active

057958955

ABSTRACT:
This is a new therapy and method used to treat moderate and severe exogenous obesity by combining generic phentermine with an SSRI (selective serotonin reuptake inhibitor) drug in specific doses for a brief or even a long duration, 12 months or more. The preferred drugs for the combination are fluoxetine hydrochloride(Prozac), sertraline (Zoloft), fluvoxamine maleate (Luvox) and trazodone hydrochloride (Desyrel).

REFERENCES:
Medical Letters on Drugs & Therapeutics vol. 36: 107-D, Nov. 1994.

Affiliated with

Also associated with

Rating

Combination anorexiant drug therapy for obesity using phentermin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination anorexiant drug therapy for obesity using phentermin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination anorexiant drug therapy for obesity using phentermin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1115016